Correlation Between Vicore Pharma and NextCell Pharma
Can any of the company-specific risk be diversified away by investing in both Vicore Pharma and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vicore Pharma and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vicore Pharma Holding and NextCell Pharma AB, you can compare the effects of market volatilities on Vicore Pharma and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vicore Pharma with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vicore Pharma and NextCell Pharma.
Diversification Opportunities for Vicore Pharma and NextCell Pharma
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vicore and NextCell is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Vicore Pharma Holding and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and Vicore Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vicore Pharma Holding are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of Vicore Pharma i.e., Vicore Pharma and NextCell Pharma go up and down completely randomly.
Pair Corralation between Vicore Pharma and NextCell Pharma
Assuming the 90 days trading horizon Vicore Pharma Holding is expected to under-perform the NextCell Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Vicore Pharma Holding is 2.83 times less risky than NextCell Pharma. The stock trades about -0.01 of its potential returns per unit of risk. The NextCell Pharma AB is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 250.00 in NextCell Pharma AB on November 2, 2024 and sell it today you would earn a total of 42.00 from holding NextCell Pharma AB or generate 16.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vicore Pharma Holding vs. NextCell Pharma AB
Performance |
| Timeline |
| Vicore Pharma Holding |
| NextCell Pharma AB |
Vicore Pharma and NextCell Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vicore Pharma and NextCell Pharma
The main advantage of trading using opposite Vicore Pharma and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vicore Pharma position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.| Vicore Pharma vs. OptiCept Technologies AB | Vicore Pharma vs. Serstech AB | Vicore Pharma vs. New Nordic Healthbrands | Vicore Pharma vs. Upsales Technology AB |
| NextCell Pharma vs. Diamyd Medical AB | NextCell Pharma vs. Mendus AB | NextCell Pharma vs. Vicore Pharma Holding | NextCell Pharma vs. Immunovia publ AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |